Literature DB >> 17664322

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.

Thomas P Lodise1, Peggy S McKinnon, Donald P Levine, Michael J Rybak.   

Abstract

This study compares beta-lactam and vancomycin among intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Patients who received vancomycin had higher infection-related mortality, even if they were switched to beta-lactam once culture results became available; this relationship persisted after logistic regression analysis controlling for clinical characteristics.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17664322      PMCID： PMC2043293          DOI： 10.1128/AAC.00101-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Outcome assessment of minimizing vancomycin monitoring and dosing adjustments.

Authors:  C M Karam; P S McKinnon; M M Neuhauser; M J Rybak
Journal:  Pharmacotherapy       Date:  1999-03       Impact factor: 4.705

Review 3.  Impact of Gram-positive resistance on outcome of nosocomial pneumonia.

Authors:  M Bodi ; C Ardanuy ; J Rello
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

4.  Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients.

Authors:  V G Fowler; L K Kong; G R Corey; G S Gottlieb; R S McClelland; D J Sexton; D Gesty-Palmer; L J Harrell
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

6.  Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms.

Authors:  C González; M Rubio; J Romero-Vivas; M González; J J Picazo
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

8.  Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users.

Authors:  J Mathew; T Addai; A Anand; A Morrobel; P Maheshwari; S Freels
Journal:  Arch Intern Med       Date:  1995 Aug 7-21

9.  Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.

Authors:  D P Levine; B S Fromm; B R Reddy
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

10.  Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.

Authors:  L Cantoni; M P Glauser; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191
View more
  31 in total

1.  Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience.

Authors:  Matteo Bassetti; Filippo Ansaldi; Daniela De Florentiis; Elda Righi; Federico Pea; Assunta Sartor; Claudio Scarparo; Alessia Carnelutti
Journal:  Intensive Care Med       Date:  2015-08-20       Impact factor: 17.440

2.  Bad bacteria in acute appendicitis: rare but relevant.

Authors:  Alexander Reinisch; Patrizia Malkomes; Nils Habbe; Wolf Otto Bechstein; Juliane Liese
Journal:  Int J Colorectal Dis       Date:  2017-07-15       Impact factor: 2.571

3.  Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.

Authors:  Zukile Gqada; Ben Marais; Elizabeth Wasserman; Colleen Bamford; Heidi Orth; George Sakoulas; Warren Rose; Michael J Rybak; Satish Pillai; Jeff Alder; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2008-07       Impact factor: 5.948

Review 4.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

5.  Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.

Authors:  G E Park; J-H Ko; S Y Cho; Y E Ha; N Y Lee; C-I Kang; D R Chung; J-H Song; K R Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-11       Impact factor: 3.267

6.  Impact of rapid diagnosis of Staphylococcus aureus bacteremia from positive blood cultures on patient management.

Authors:  M P Romero-Gómez; E Cendejas-Bueno; J García Rodriguez; J Mingorance
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-23       Impact factor: 3.267

7.  New perspectives of infections in cardiovascular disease.

Authors:  Ignatius W Fong
Journal:  Curr Cardiol Rev       Date:  2009-05

8.  Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.

Authors:  Christian Joukhadar; Satish Pillai; Christine Wennersten; Robert C Moellering; George M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

9.  Adverse Events Lead to Drug Discontinuation More Commonly among Patients Who Receive Nafcillin than among Those Who Receive Oxacillin.

Authors:  J Alexander Viehman; Louise-Marie Oleksiuk; Kathleen R Sheridan; Karin E Byers; Peimei He; Bonnie A Falcione; Ryan K Shields
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

10.  Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.

Authors:  Kanokporn Mongkolrattanothai; Jean C Aldag; Peggy Mankin; Barry M Gray
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.